Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5071751 | 0.78 | KDM4E (0.34) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL7029700 | 0.75 | KDM4E (0.40) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL4402348 | 0.74 | KDM4E (0.47) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL14449006 | 0.74 | KDM4E (0.47) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL5718788 | 0.72 | KDM4E (0.41) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL4967419 | 0.72 | KDM4E (0.41) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL472764 | 0.72 | KDM4E (0.41) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL4967632 | 0.72 | KDM4E (0.41) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL5053685 | 0.72 | EPHX2 (0.36) | KDM4ELMNAALDH1A1GAATDP1 | |
| SCHEMBL12256170 | 0.71 | KDM4E (0.37) | KDM4ELMNAALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505197-A | Low-temperature-cured high-toughness polyester resin and preparation method and application thereof | 擎天材料科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-115181397-B | 3D printable high-strength high-toughness thermosetting resin composite material and preparation method and application thereof | 南京林业大学 | 2023-11-21 | — | — | CN | claimed |
| CN-116284621-A | Cycloolefin multiblock copolymer and preparation method and application thereof | 南方科技大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115181397-A | High-strength high-toughness thermosetting resin composite material capable of being printed in 3D mode and preparation method and application thereof | 南京林业大学 | 2022-10-14 | — | — | CN | claimed |
| CN-116284621-B | Cycloolefin multiblock copolymer and preparation method and application thereof | 南方科技大学 | 2026-05-19 | — | — | CN | disclosed |
| US-20250163418-A1 | Brush polymer-oligonucleotide conjugates for the treatment of muscular dystrophy | UNIV NORTHEASTERN (US) | 2025-05-22 | — | — | US | disclosed |
| CN-119505197-A | Low-temperature-cured high-toughness polyester resin and preparation method and application thereof | 擎天材料科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-117545511-A | Thiol coupling with unsaturated phosphorus (V) compounds | 柏林合作研究学会 | 2024-02-09 | — | — | CN | disclosed |
| CN-115181397-B | 3D printable high-strength high-toughness thermosetting resin composite material and preparation method and application thereof | 南京林业大学 | 2023-11-21 | — | — | CN | disclosed |
| CN-116284621-A | Cycloolefin multiblock copolymer and preparation method and application thereof | 南方科技大学 | 2023-06-23 | — | — | CN | disclosed |
| US-20230144534-A1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-05-11 | — | — | US | disclosed |
| CN-115884792-A | Targeted poly (beta-amino esters) | 艾夏卡法国有限公司 | 2023-03-31 | — | — | CN | disclosed |
| US-20190292310-A1 | SYNTHESIS OF HIGH DENSITY MOLECULAR DNA BRUSHES VIA ORGANIC-PHASE RING-OPENING METATHESIS (CO)POLYMERIZATION | NATIONAL SCIENCE FOUNDATION | 2019-09-26 | — | — | US | disclosed |
| US-7714087-B2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2010-05-11 | — | — | US | disclosed |
| EP-1734061-B1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof | MITSUI CHEMICALS INC (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20090137757-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | IMUTA JUNICHI | 2009-05-28 | — | — | US | disclosed |
| US-7393907-B2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2008-07-01 | — | — | US | disclosed |
| US-6048664-A | Energy-sensitive resist material and a process for device fabrication using an energy-sensitive resist material | LUCENT TECHNOLOGIES, INC. (US) | 2000-04-11 | — | — | US | disclosed |
| US-4897473-A | Homologation of carbonyloxy containing compounds | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) | 1990-01-30 | — | — | US | disclosed |
| EP-0064287-A1 | Homologation of carbonyloxy containing compounds and catalyst therefor | UNION CARBIDE CORPORATION (US) | 1982-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230144534-A1 | CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION | KIT, TPSB2, BTD | KDM4E 2183/4885LMNA 1516/4885ALDH1A1 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.